Inhibrx secures $10m credit facility from Oxford

Oxford Finance LLC has provided a $10 million credit facility to Inhibrx Inc, a clinical-stage biotechnology company.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this